This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Progress In Treating Cancer In The U.S. Continues To Surge, Surpassing 50 Million Life-years Saved

About is a community of patients, advocates, innovators and concerned citizens working together to generate awareness of the Value of Medical Innovation to longer life, better health and increased economic well-being. We believe that a world free from cancer is possible if we reduce the time it takes to develop new cancer treatments and get them to patients. We seek to ensure that health plans and government policies encourage use of personalized treatment of tumors. also promotes collective action to remove the obstacles to using rapid advances in science to make cancer a preventable and manageable illness. is an independent project of The Center for Medicine in the Public Interest (CMPI, CMPI has promoted public-private partnerships to accelerate and protect medical innovation, developed a pathway for personalized medicine and raised concerns about the use of comparative effectiveness research on innovation and access to treatment. The Value of Medical Innovation initiative is in line with the CMPI's mission. The CMPI is dedicated to promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered.

The methodology of the Life-Years-Saved Clock and other information about the relationship between innovation and progress against cancer can be found at

About CMPI

The Center for Medicine in the Public Interest is a nonprofit, nonpartisan research and educational organization that seeks to advance the discussion and development of the value of medical innovation.

SOURCE Center for Medicine in the Public Interest

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


Chart of I:DJI
DOW 16,068.84 -305.92 -1.87%
S&P 500 1,914.49 -36.64 -1.88%
NASDAQ 4,666.8580 -66.6390 -1.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs